20.36
BATS BZX Real-Time Price
As of 10:03am ET
 +0.36 / +1.80%
Today’s Change
2.47
Today|||52-Week Range
22.53
+154.18%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$546.4M

Company Description

Advaxis, Inc. is a clinical-stage biotechnology company, which intends to develop immunotherapies for cancer and infectious diseases. The company's platform technology is designed to generate a comprehensive immune response by serving as its own adjuvant, directing antigen presentation, increasing tumor infiltrating killer T-cells, and decreasing Tregs/MDSCs in the tumor. Advaxis was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Contact Information

Advaxis, Inc.
305 College Road East
Princeton New Jersey 08540
P:(609) 452-9813
Investor Relations:

Employees

Shareholders

Individual stakeholders23.66%
Other institutional23.08%
Mutual fund holders13.92%

Top Executives

Daniel J. O'ConnorPresident, Chief Executive Officer & Director
Gregory T. MayesCOO, Secretary, EVP & Head-Investor Relations
Sara BonsteinChief Financial Officer & Senior Vice President
Robert PetitChief Scientific Officer & Executive VP
Christy Lee FrenchVice President-Regulatory & Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account